2008 | 2007 | 2006 | 2005 | 2004 | 2003
|
| December 18, 2007 |
 Results of Vasogen’s Phase III ACCLAIM Trial Accepted for Publication in The Lancet |
 |
| December 17, 2007 |
| Vasogen Provides an Update on ACCLAIM-II Preparations |
|
| December 17, 2007 |
| Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade |
|
| November 1, 2007 |
| Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences |
|
| October 9, 2007 |
| Vasogen Announces Third Quarter 2007 Results |
|
| October 2, 2007 |
| Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation |
|
| September 19, 2007 |
| Dr. James Young Appointed Principal Investigator for Vasogen’s Confirmatory Study in NYHA Class II Heart Failure |
|
| September 17, 2007 |
| Vasogen Plans Confirmatory Study of Celacade™ in Chronic Heart Failure to Support U.S. Regulatory Approval |
|
| July 10, 2007 |
| Vasogen Announces Second Quarter 2007 Results |
|
| June 28, 2007 |
| Vasogen to Conduct Quarterly Conference Call |
|
| June 27, 2007 |
| Vasogen Reports on Outcome of FDA Meeting |
|
| June 20, 2007 |
| Chris Waddick Appointed President and CEO of Vasogen |
|
| May 24, 2007 |
| Vasogen Closes Previously Announced Financing |
|
| May 18, 2007 |
| Vasogen Raises US$16 Million Through Sale of Common Shares and Warrants |
|
| May 18, 2007 |
| Vasogen to Present at the Sixth Annual JMP Securities Research Conference |
|
| May 8, 2007 |
| Vasogen to Webcast Presentation at the Acumen BioFin Rodman & Renshaw Global Healthcare Conference |
|
| May 3, 2007 |
| Vasogen to Trade Under Former NASDAQ Trading Symbol ‘VSGN’ Effective May 15th |
|
| May 2, 2007 |
| Vasogen Regains Compliance with Nasdaq Minimum Bid Listing Requirement |
|
| April 18, 2007 |
| Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade™ in the European Union |
|
| April 16, 2007 |
| Vasogen Announces Effective Date for Reverse Stock Split |
|
| April 11, 2007 |
| Vasogen Announces Senior Management Changes |
|
| April 9, 2007 |
| Vasogen Announces First Quarter 2007 Results |
|
| March 28, 2007 |
| Vasogen to Conduct Webcast and Conference Call of Annual Meeting |
|
| March 7, 2007 |
| Vasogen Appoints Terry H. Gregg President & CEO |
|
| February 21, 2007 |
| Vasogen Files Prospectus Supplement |
|
| February 8, 2007 |
| Vasogen Selected to Participate in “The Horizon of New Cardiovascular Drugs” Panel at BIO CEO & Investor Conference 2007 |
|
| February 7, 2007 |
| Vasogen to Transfer to NASDAQ Capital Market |
|
| January 31, 2007 |
| Vasogen Announces 2006 Year-end Results |
|
| January 23, 2007 |
| Vasogen to Conduct Year-end Conference Call |
|
Home 
Contact Us 
Search 
Site Map 
Printable Page